Essex Investment Management CO LLC Harvard Bioscience Inc Transaction History

Essex Investment Management CO LLC

$483 Million
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.28 - $6.42 $1.42 Million - $2.77 Million	-431,848 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$5.16 - $7.14 $103,060 - $142,607	19,973 Added 4.85%	431,848 $2.68 Million
Q4 2021 Feb 10, 2022	BUY	$6.37 - $8.18 $198,355 - $254,717	31,139 Added 8.18%	411,875 $2.9 Million
Q3 2021 Nov 09, 2021	SELL	$6.98 - $8.47 $17,080 - $20,726	-2,447 Reduced 0.64%	380,736 $2.66 Million
Q2 2021 Aug 12, 2021	BUY	$5.44 - $8.4 $449,708 - $694,402	82,667 Added 27.51%	383,183 $0

Q1 2021 May 12, 2021	SELL	$3.91 - $6.99 $123,552 - $220,877	-31,599 Reduced 9.51%	300,516 $1.64 Million
Q4 2020 Feb 12, 2021	SELL	$3.0 - $4.5 $187,122 - $280,683	-62,374 Reduced 15.81%	332,115 $1.43 Million
Q3 2020 Nov 12, 2020	BUY	$2.75 - $4.2 $400,545 - $611,742	145,653 Added 58.53%	394,489 $1.19 Million
Q2 2020 Aug 04, 2020	SELL	$2.12 - $3.14 $2,467 - $3,654	-1,164 Reduced 0.47%	248,836 $771,000
Q1 2020 May 04, 2020	SELL	$1.42 - $3.29 $389,454 - $902,328	-274,264 Reduced 52.31%	250,000 $553,000
Q4 2019 Feb 10, 2020	BUY	$2.45 - $3.25 $60,387 - $80,106	24,648 Added 4.93%	524,264 $1.6 Million
Q3 2019 Oct 22, 2019	SELL	$1.59 - $3.47 $91,059 - $198,726	-57,270 Reduced 10.28%	499,616 $1.54 Million
Q2 2019 Aug 15, 2019	BUY	$1.93 - $4.59 $155,544 - $369,921	80,593 Added 16.92%	556,886 $1.11 Million
Q1 2019 May 15, 2019	SELL	$2.77 - $4.38 $36,414 - $57,579	-13,146 Reduced 2.69%	476,293 $2.05 Million
Q4 2018 Feb 06, 2019	SELL	$3.03 - $5.0 $98,278 - $162,175	-32,435 Reduced 6.22%	489,439 $1.56 Million
Q3 2018 Oct 16, 2018	BUY	$5.0 - $6.65 $106,650 - $141,844	21,330 Added 4.26%	521,874 $2.74 Million
Q2 2018 Jul 17, 2018	BUY	$4.2 - $5.95 $2,562 - $3,629	610 Added 0.12%	500,544 $2.68 Million
Q1 2018 Apr 26, 2018	SELL	$3.3 - $5.15 $121,265 - $189,247	-36,747 Reduced 6.85%	499,934 $2.5 Million
Q4 2017 Feb 05, 2018	SELL	$3.08 - $3.8 $12,745 - $15,724	-4,138 Reduced 0.77%	536,681 $1.77 Million
Q3 2017 Oct 30, 2017	BUY	$2.7 - $3.75 $1.46 Million - $2.03 Million	540,819	540,819 $2.03 Million

Others Institutions Holding HBIO

# of Institutions

Shares Held

32.8M

Call Options Held

Put Options Held

2.2K

B. Riley Asset Management, LLC Dallas, TX

2.83M
Shares

$8.08 Million
5.14% of portfolio
Black Rock Inc. New York, NY

2.83M
Shares

$8.08 Million
0.0% of portfolio
Punch & Associates Investment Management, Inc. Edina, MN

2.77M
Shares

$7.9 Million
0.71% of portfolio
Harvey Partners, LLC Tarrytown, NY

2.56M
Shares

$7.29 Million
1.17% of portfolio
Amh Equity LTD

2.32M
Shares

$6.62 Million
10.16% of portfolio

View Full List

About HARVARD BIOSCIENCE INC

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $119M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

More about HBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Account